| 000 | 01748 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518033913.0 | ||
| 264 | 0 | _c20190919 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1532-2335 | ||
| 024 | 7 |
_a10.1080/15257770.2018.1541466 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPopova, Elena A | |
| 245 | 0 | 0 |
_aSynthesis and _h[electronic resource] |
| 260 |
_bNucleosides, nucleotides & nucleic acids _c2019 |
||
| 300 |
_a713-731 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aAntiviral Agents _xchemical synthesis |
| 650 | 0 | 4 | _aCatalysis |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCopper _xchemistry |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aCycloaddition Reaction |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza A Virus, H1N1 Subtype _xdrug effects |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTetrazoles _xchemistry |
| 650 | 0 | 4 |
_aThymidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aTriazoles _xchemistry |
| 700 | 1 | _aOvsepyan, Gayane K | |
| 700 | 1 | _aProtas, Aleksandra V | |
| 700 | 1 | _aErkhitueva, Elena B | |
| 700 | 1 | _aKukhanova, Marina K | |
| 700 | 1 | _aYesaulkova, Yana L | |
| 700 | 1 | _aZarubaev, Vladimir V | |
| 700 | 1 | _aStarova, Galina L | |
| 700 | 1 | _aSuezov, Roman V | |
| 700 | 1 | _aEremin, Alexei V | |
| 700 | 1 | _aOstrovskii, Vladimir A | |
| 700 | 1 | _aTrifonov, Rostislav E | |
| 773 | 0 |
_tNucleosides, nucleotides & nucleic acids _gvol. 38 _gno. 10 _gp. 713-731 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/15257770.2018.1541466 _zAvailable from publisher's website |
| 999 |
_c29595344 _d29595344 |
||